Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients

Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients

Bibliographic Details
Main Authors:	Marcello Disertori, Michela Masè, Marta Rigoni, Giandomenico Nollo, Eloisa Arbustini, Flavia Ravelli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-10-01
Series:	Frontiers in Physiology
Subjects:	ventricular arrhythmias sudden cardiac death implantable cardioverter-defibrillator dilated cardiomyopathy genetics heart failure
Online Access:	http://journal.frontiersin.org/article/10.3389/fphys.2017.00873/full

Similar Items

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
by: Maciej Kempa, et al.
Published: (2021-07-01)

Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention
by: Kyoichiro Yazaki, et al.
Published: (2021-02-01)

Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study
by: Shinichi Niwano, et al.
Published: (2021-02-01)

Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD “Monaldi Care” registry
by: Berardo Sarubbi, et al.
Published: (2021-05-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Arrhythmic Sudden Cardiac Death and the Role of Implantable Cardioverter-Defibrillator in Patients with Cardiac Amyloidosis—A Narrative Literature Review
by: Aleksandra Liżewska-Springer, et al.
Published: (2021-04-01)

Real world utilization and impact of the wearable cardioverter-defibrillator in a community setting
by: Aditi Naniwadekar, et al.
Published: (2017-05-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

The wearable cardioverter-defibrillator is needed for most high-risk patients
by: Byron K. Lee, MD, MAS
Published: (2020-08-01)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
by: Florian Blaschke, et al.
Published: (2021-08-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
by: Pier D. Lambiase, MBChB, PhD, FHRS, et al.
Published: (2020-12-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Practical Review and Real-World Use and Application
by: Mark E. Panna Jr, MD, FACC, FHRS, et al.
Published: (2016-02-01)

Coronary vein defibrillator coil placement in patients with high defibrillation thresholds
by: Moisés Rodríguez‐Mañero, et al.
Published: (2019-02-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
by: Jayasree Pillarisetti, MD, et al.
Published: (2015-01-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
by: Fernando Sérgio Oliva Souza, et al.

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
by: Nobuhiro Nishii, MD, et al.
Published: (2017-08-01)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
by: Yisachar Greenberg, et al.
Published: (2005-04-01)

Cost-effectiveness of implantable cardioverter-defibrillator in today's world
by: Giuseppe Boriani, et al.
Published: (2014-01-01)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
by: Alwin B. P. Noordman, et al.
Published: (2021-08-01)

Magnets and implantable cardioverter defibrillators: What′s the problem?
by: Yiliam F Rodriguez-Blanco, et al.
Published: (2013-01-01)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
by: Matthew F. Yuyun, MD, MPhil, PhD, et al.
Published: (2020-05-01)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
by: Mohammad Reza Dehghani, et al.
Published: (2006-01-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker
by: Paul S.G. Hong, MRCP, et al.
Published: (2015-01-01)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
by: Anne‐Lotte C.J. van derLingen, et al.
Published: (2021-10-01)

Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators
by: Valeria Rella, et al.
Published: (2020-04-01)

Main air pollutants and ventricular arrhythmias in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis
by: Hong-Jie Yang, et al.
Published: (2017-12-01)

Implantable cardioverter defibrillator therapy for secondary prevention in spontaneous coronary artery dissection: to place or not to place? This is the matter
by: Riccardo Scagliola, et al.
Published: (2020-03-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Factors That Cause Concerns after Cardioverter Defibrillator Implantation
by: Olimpia Karczewska, et al.
Published: (2021-06-01)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
by: Johnson Francis, et al.
Published: (2005-04-01)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
by: Advay G. Bhatt, MD, FHRS, et al.
Published: (2020-08-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)